Skip to main content

Table 4 The relations between depression dimensional profilers’ scores and metabolic-inflammatory impairments

From: Evaluation of inflammatory and metabolic impairments regarding depression dimensions: a case control study

  Atypical, energy-related symptom dimension (0–15)
Median scores (%)
Melancholic symptom dimension (0–24)
Median scores (%)
Childhood trauma symptom dimension (0–8)
Median scores (%)
Anxious distress symptom dimension (0–15)
Median scores (%)
Test of significance
Hypertensive patients
(n = 41)
12.3 (82%) 9.2 (38.3%) 3.3 (41.2%) 8.1 (54%) p < 0.001*
Impaired glycemic control
(n = 36)
12.9 (86%) 7.4 (30.8%) 2.6 (32.5%) 11.7 (78%) p < 0.001*
Elevated LDL/HDL ratio
(n = 64)
11.8 (78.6%) 10.1 (42%) 3.1 (38.7%) 6.8 (45.3%) p = 0.038*
Elevated TGS
(n = 61)
12.1 (80.6%) 8.9 (37%) 3.7 (46.2%) 6.4 (42.6%) p = 0.026*
Central obesity
(n = 57)
13 (86.6%) 9 (37.5%) 3 (37.5%) 6 (40%) p = 0.004*
Elevated CRP
(n = 34)
9.2 (61.3%) 11.3 (47%) 6.8 (85%) 7.3 (48.6%) p= .009*
  1. *Statistically significant if p < 0.05